These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 16909812)
1. Development of nasal skin necrosis associated with rituximab treatment for Waldenström's macroglobulinemia and subsequent spontaneous resolution. Pearlman AN; Fechner FP; Constantinides M Ear Nose Throat J; 2006 Jul; 85(7):431-3. PubMed ID: 16909812 [TBL] [Abstract][Full Text] [Related]
2. [Effective treatment with rituximab in two patients with Waldenström macroglobulinemia]. Yoshimi A; Arai S; Iijima K; Iki S; Usuki K; Urabe A Rinsho Ketsueki; 2005 Oct; 46(10):1109-13. PubMed ID: 16440772 [TBL] [Abstract][Full Text] [Related]
3. Case of mononeuritis multiplex onset with rituximab therapy for Waldenström's macroglobulinemia. Mauermann ML; Ryan ML; Moon JS; Klein CJ J Neurol Sci; 2007 Sep; 260(1-2):240-3. PubMed ID: 17537458 [TBL] [Abstract][Full Text] [Related]
4. Proinflammatory syndrome mimicking acute rheumatoid arthritis in a patient with Waldenstrom's macroglobulinemia treated with rituximab. Buda-Okreglak EM; Drabick JJ; Delaney NR Ann Hematol; 2004 Feb; 83(2):117-9. PubMed ID: 14513285 [TBL] [Abstract][Full Text] [Related]
5. An unusual reoccurrence of Waldenstrom's macroglobulinemia as pleural effusions that had a discordant response with treatment. Amin CJ; Rabinowitz I Clin Lab Haematol; 2005 Jun; 27(3):200-2. PubMed ID: 15938727 [TBL] [Abstract][Full Text] [Related]
6. Acute renal failure secondary to severe type I cryoglobulinemia following rituximab therapy for Waldenström's macroglobulinemia. Shaikh A; Habermann TM; Fidler ME; Kumar S; Leung N Clin Exp Nephrol; 2008 Aug; 12(4):292-295. PubMed ID: 18288560 [TBL] [Abstract][Full Text] [Related]
7. Rituximab-based treatments in Waldenström's macroglobulinemia. Dimopoulos MA; Kastritis E; Roussou M; Eleutherakis-Papaiakovou E; Migkou M; Gavriatopoulou M; Tassidou A; Terpos E Clin Lymphoma Myeloma; 2009 Mar; 9(1):59-61. PubMed ID: 19362975 [TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma followed by Waldenström's macroglobulinemia: a case report. Hasegawa K; Kubota K; Hirai H; Imai Y; Midorikawa Y; Makuuchi M Hepatogastroenterology; 2000; 47(33):842-5. PubMed ID: 10919044 [TBL] [Abstract][Full Text] [Related]
9. Cutaneous Waldenstrom's macroglobulinemia with "deck-chair" sign treated with cyclophosphamide. Autier J; Buffet M; Pinquier L; Merlat-Guitard AI; Carlotti A; Franck N; Gorin I; Dupin N J Am Acad Dermatol; 2005 Feb; 52(2 Suppl 1):45-7. PubMed ID: 15692513 [TBL] [Abstract][Full Text] [Related]
10. A review of rituximab in cutaneous medicine. Scheinfeld N Dermatol Online J; 2006 Jan; 12(1):3. PubMed ID: 16638371 [TBL] [Abstract][Full Text] [Related]
11. Flare in neuropathy following rituximab therapy for Waldenstrom's macroglobulinemia. Noronha V; Fynan TM; Duffy T J Clin Oncol; 2006 Jan; 24(1):e3. PubMed ID: 16382111 [No Abstract] [Full Text] [Related]
12. Gangrenous, hemorrhagic, bullous cellulitis associated with pseudomonas aeruginosa in a patient with Waldenström's macroglobulinemia. Falagas ME; Pappas VD; Michalopoulos A Infection; 2007 Oct; 35(5):370-3. PubMed ID: 17721738 [TBL] [Abstract][Full Text] [Related]
13. [Association of sarcoidosis and Waldenström's macroglobulinemia]. Collet E; Boulitrop-Morvan C; Dalac S; Camus P; Lambert D Ann Dermatol Venereol; 1992; 119(12):971-4. PubMed ID: 1304690 [TBL] [Abstract][Full Text] [Related]
14. Idelalisib in a patient with refractory Waldenström's macroglobulinemia complicated by anuric renal failure: a case report. D'Aveni-Piney M; Divoux M; Busby-Venner H; Muller M; Broséus J; Feugier P J Med Case Rep; 2018 Jun; 12(1):164. PubMed ID: 29890999 [TBL] [Abstract][Full Text] [Related]
15. [Complete response achieved after rituximab plus CHOP therapy in a patient with rapidly progressing Waldenstrom's macroglobulinemia]. Ise M; Sakai C; Kumagai K Rinsho Ketsueki; 2009 Jan; 50(1):34-8. PubMed ID: 19225227 [TBL] [Abstract][Full Text] [Related]
16. Novel agents in the treatment of Waldenström's macroglobulinemia. Treon SP; Hatjiharissi E; Leleu X; Moreau AS; Roccaro A; Hunter ZR; Soumerai JD; Ciccarelli B; Xu L; Sacco A; Ngo HT; Jia X; Yang C; Adamia S; Branagan AR; Ho AW; Santos DD; Tournilhac O; Manning RJ; Leduc R; O'Connor K; Nelson M; Patterson CJ; Ghobrial I Clin Lymphoma Myeloma; 2007 Aug; 7 Suppl 5():S199-206. PubMed ID: 17877845 [TBL] [Abstract][Full Text] [Related]